Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Letter to the Editor referring to the retracted publication entitled "Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment" by Hwang et al.

Hwang JTK, Gu YR, Dickson BJ, Shen M, Ralhan R, Walfish PG, Mock D, Pritzker KPH.

Oral Oncol. 2018 May;80:103. doi: 10.1016/j.oraloncology.2018.03.012. Epub 2018 Mar 23. No abstract available.

PMID:
29580748
2.

RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment.

Hwang JTK, Gu YR, Dickson BJ, Shen M, Ralhan R, Walfish PG, Mock D, Pritzker KPH.

Oral Oncol. 2017 Sep;72:1-6. doi: 10.1016/j.oraloncology.2017.06.024. Epub 2017 Jun 29. Erratum in: Oral Oncol. 2018 Feb;77:138.

PMID:
28797444
3.

RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment.

Hwang JTK, Gu YR, Dickson BJ, Shen M, Ralhan R, Walfish PG, Mock D, Pritzker KPH.

Oral Oncol. 2018 Feb;77:138. doi: 10.1016/j.oraloncology.2017.12.019. No abstract available.

PMID:
29362120
4.

Individualized five-year risk assessment for oral premalignant lesion progression to cancer.

Hwang JT, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KP, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Mar;123(3):374-381. doi: 10.1016/j.oooo.2016.11.004. Epub 2016 Nov 22.

PMID:
28110942
5.
6.

Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.

AbdulMajeed AA, Dalley AJ, Farah CS.

Ann Diagn Pathol. 2013 Aug;17(4):331-40. doi: 10.1016/j.anndiagpath.2013.03.003. Epub 2013 May 3.

PMID:
23643910
7.

Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.

Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, Warnakulasuriya S, Møller H, Odell EW.

Cancer Prev Res (Phila). 2013 Aug;6(8):822-31. doi: 10.1158/1940-6207.CAPR-13-0001. Epub 2013 Jun 12.

8.

Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.

Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, Senguven B, McConkey C, Rabbitts P, Mehanna H.

J Oral Pathol Med. 2014 Apr;43(4):245-9. doi: 10.1111/jop.12128. Epub 2013 Dec 26.

9.

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia.

Nankivell P, Williams H, McConkey C, Webster K, High A, MacLennan K, Senguven B, Rabbitts P, Mehanna H.

Br J Cancer. 2013 Nov 26;109(11):2864-74. doi: 10.1038/bjc.2013.600. Epub 2013 Nov 7.

10.
11.

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement.

Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E.

J Oral Pathol Med. 2008 Mar;37(3):127-33. doi: 10.1111/j.1600-0714.2007.00584.x.

PMID:
18251935
12.

The clinical determinants of malignant transformation in oral epithelial dysplasia.

Ho MW, Risk JM, Woolgar JA, Field EA, Field JK, Steele JC, Rajlawat BP, Triantafyllou A, Rogers SN, Lowe D, Shaw RJ.

Oral Oncol. 2012 Oct;48(10):969-976. doi: 10.1016/j.oraloncology.2012.04.002. Epub 2012 May 10.

PMID:
22579265
13.

Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases.

Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT.

Histopathology. 2011 Oct;59(4):733-40. doi: 10.1111/j.1365-2559.2011.03938.x. Epub 2011 Sep 14.

PMID:
21916948
15.

Immunohistochemical evaluation of oral epithelial dysplasia using cyclin-D1, p27 and p63 expression as predictors of malignant transformation.

Ramasubramanian A, Ramani P, Sherlin HJ, Premkumar P, Natesan A, Thiruvengadam C.

J Nat Sci Biol Med. 2013 Jul;4(2):349-58. doi: 10.4103/0976-9668.117011.

16.
18.

Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.

Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Cowan CG, Gregg TA, Maxwell P, Meijer CJ.

J Clin Pathol. 2002 Feb;55(2):98-104.

19.

Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.

Ho MW, Field EA, Field JK, Risk JM, Rajlawat BP, Rogers SN, Steele JC, Triantafyllou A, Woolgar JA, Lowe D, Shaw RJ.

Br J Oral Maxillofac Surg. 2013 Oct;51(7):594-9. doi: 10.1016/j.bjoms.2013.03.014. Epub 2013 Apr 16.

PMID:
23601832

Supplemental Content

Support Center